Li, Y., Xi, Z., Chen, X., Cai, S., Liang, C., Wang, Z., . . . Xu, H. Correction to: Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways. Nature Publishing Group.
Chicago Style (17th ed.) CitationLi, Yang, et al. Correction to: Natural Compound Oblongifolin C Confers Gemcitabine Resistance in Pancreatic Cancer by Downregulating Src/MAPK/ERK Pathways. Nature Publishing Group.
MLA (9th ed.) CitationLi, Yang, et al. Correction to: Natural Compound Oblongifolin C Confers Gemcitabine Resistance in Pancreatic Cancer by Downregulating Src/MAPK/ERK Pathways. Nature Publishing Group.
Warning: These citations may not always be 100% accurate.